Srs Formulations Private Limited, a active private limited company, was established on 09 July 2014 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999MH2014PTC255945. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹70.00 Cr and a paid-up capital of ₹4.15 Cr.
Formerly known as Adkure Pharmaceuticals Private Limited, Adkure Technologies Private Limited. It upholds a compliant status. Employing 25 professional, Its leadership includes Kishen Jee Kaul (Director), Manoj Kumar Sharma (Director). Past directors included Kishen Jee Kaul, Manoj Kumar Sharma, Suchet Shyamsunder Rastogi. It holds ₹4.80 Cr open charges and ₹12.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at U No. 504, Marathon Max,, Link Road, Mulund West, Mumbai, Maharashtra, 400080.
U74999MH2014PTC255945
255945
09 July 2014
₹70.00 Cr
₹4.15 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Srs Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kishen Jee Kaul | Director | 10 Nov 2023 | Current |
| Manoj Kumar Sharma | Director | 26 Dec 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Dec 2023 | Past |
| Pramod Abcsdd | Additional Director | 28 Dec 2023 | Past |
| Pramod Abcsdd | Director | 21 Nov 2023 | Past |
| Pramod Abcsdd | Director | 05 Mar 2016 | Past |
| Pramod Abcsdd | Director | 26 Dec 2022 | Past |
| Pramod Abcsdd | Director | 26 Dec 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Srs Formulations Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Srs Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹48,000,000.00
₹120,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jul 2025 | Hdfc Bank Limited | ₹4.80 Cr | Open |
| 17 Feb 2017 | Sidbi | ₹12.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Srs Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Srs Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srs Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Srs Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 4.80 Cr with Charge ID 101128823 was registered on 07 Jul 2025. was documented.
The activity Srs Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
The activity Komal Dilip Jain was appointed as a Company Secretary was appointed as a Company Secretary on 05 Sep 2024 & has been associated with this company since 1 year 4 months . was completed.
Progress on Kishen Jee Kaul was appointed as a Director was appointed as a Director on 10 Nov 2023 & has been associated with this company since 2 years 1 month . was documented.
The activity Manoj Kumar Sharma was appointed as a Director was appointed as a Director on 26 Dec 2022 & has been associated with this company since 3 years 9 days . was completed.
The CIN of Srs Formulations Private Limited is U74999MH2014PTC255945.
Srs Formulations Private Limited is headquartered at U No. 504, Marathon Max,, Link Road, Mulund West, Mumbai, Maharashtra, 400080.
Srs Formulations Private Limited was incorporated on 09 July 2014.
The current directors of Srs Formulations Private Limited are
The primary industry of Srs Formulations Private Limited is Pharma.
Srs Formulations Private Limited is unlisted.
The authorized capital of Srs Formulations Private Limited is ₹70.00 Cr, and the paid-up capital is ₹4.15 Cr.
The compliance status of Srs Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX